Due to the introduction of improved, more cost-efficient target capture technologies, NGS-based applications have become the standard of care in human genetics. Large NGS assays and exome analysis generate huge amounts of data that need to be processed and interpreted and are often underutilized in clinical practice. The identification and interpretation of relevant genetic variants to provide accurate clinical recommendations is still considered a major challenge, as various genetic and clinical aspects need to be carefully evaluated.

In this webinar, speakers from Limbus Medical Technologies, MGZ, and Genomenon share their perspectives on what is necessary to successfully accept challenges in clinical routine and what tools are available and needed to accelerate and improve the diagnostic process.